Williams R H, Maggiore J A, Reynolds R D, Helgason C M
Department of Pathology, University of Illinois at Chicago Medical Center, 840 South Wood Street, 201G CSB, Chicago, IL 60612, USA.
Clin Chem. 2001 Jun;47(6):1031-9.
Plasma "redox" status can be assessed by measurements of reduced (r)-, free (f)-, oxidized (ox)-, and protein-bound (b)-homocysteine (Hcy) plus the related aminothiols cysteine, cysteinylglycine (CysGly), and glutathione (GSH), but sample collection has been complex. The redox status has not been determined in ischemic stroke patients and may provide increased understanding of its role in pathogenesis. We wished to examine the feasibility of this measurement in samples collected in readily available acidic sodium citrate.
We measured aminothiols and their stability in stabilized protein-free filtrate using acidic sodium citrate (BioPool Stabilyte, pH 4.3) vs EDTA whole blood. Before analysis, plasma samples were also ultrafiltered to obtain a protein-free filtrate. The concentrations of total Hcy (tHcy), fHcy, and rHcy and their related aminothiols, cysteine, cysteinylglycine, and glutathione were simultaneously determined on acidic sodium-citrated blood using reversed-phase HPLC with fluorescence detection. Bound and oxidized aminothiols were calculated by difference using the concentrations of the total, free, and reduced fractions. Using this approach, we compared the redox status in newly diagnosed ischemic stroke patients (n = 20) and healthy age- and sex-matched subjects (n = 20).
tHcy, tCys, tCysGly, and tGSH concentrations in whole blood with Stabilyte were stable for 8 h; the reduced fraction of each aminothiol was stable for 4 h. Recovery in the protein-free filtrate was 90-100% for all reduced thiols in acidified sodium-citrated blood. Patients with ischemic stroke had higher plasma tHcy, fHcy, bHcy, rHcy, and oxHcy (P <0.0005) and higher plasma t-, f-, r-, and oxCys (P <0.05). t-, b-, and rCysGly concentrations were lower in the stroke patients (P <0.05), as were t-, b-, and oxGSH (P <0.005).
Collection of blood in acidic sodium citrate (BioPool Stabilyte) permits the determination of the redox status of Hcy and its related aminothiols, which may add to the understanding of their relationship to the etiology of cerebrovascular disease.
血浆“氧化还原”状态可通过测量还原型(r)、游离型(f)、氧化型(ox)和蛋白结合型(b)同型半胱氨酸(Hcy)以及相关的氨基硫醇半胱氨酸、半胱氨酰甘氨酸(CysGly)和谷胱甘肽(GSH)来评估,但样本采集过程较为复杂。缺血性脑卒中患者的氧化还原状态尚未确定,这可能有助于加深对其在发病机制中作用的理解。我们希望检验在易于获取的酸性枸橼酸钠中采集的样本中进行这种测量的可行性。
我们使用酸性枸橼酸钠(BioPool Stabilyte,pH 4.3)与乙二胺四乙酸(EDTA)全血比较了氨基硫醇及其在稳定的无蛋白滤液中的稳定性。在分析前,血浆样本也经过超滤以获得无蛋白滤液。使用反相高效液相色谱结合荧光检测法同时测定酸性枸橼酸钠抗凝血液中总同型半胱氨酸(tHcy)、游离同型半胱氨酸(fHcy)和还原型同型半胱氨酸(rHcy)及其相关的氨基硫醇、半胱氨酸、半胱氨酰甘氨酸和谷胱甘肽的浓度。结合型和氧化型氨基硫醇通过总浓度、游离浓度和还原浓度的差值计算得出。采用这种方法,我们比较了新诊断的缺血性脑卒中患者(n = 20)和年龄及性别匹配的健康受试者(n = 20)的氧化还原状态。
使用Stabilyte抗凝的全血中tHcy、总半胱氨酸(tCys)、总半胱氨酰甘氨酸(tCysGly)和总谷胱甘肽(tGSH)浓度在8小时内保持稳定;每种氨基硫醇的还原型部分在4小时内保持稳定。酸化枸橼酸钠抗凝血液中所有还原型硫醇在无蛋白滤液中的回收率为90 - 100%。缺血性脑卒中患者的血浆tHcy、fHcy、bHcy、rHcy和oxHcy水平较高(P <0.0005),血浆总半胱氨酸、游离半胱氨酸、还原型半胱氨酸和氧化型半胱氨酸水平也较高(P <0.05)。脑卒中患者的总、结合型和还原型半胱氨酰甘氨酸浓度较低(P <0.05),总、结合型和氧化型谷胱甘肽浓度也较低(P <0.005)。
在酸性枸橼酸钠(BioPool Stabilyte)中采集血液可测定同型半胱氨酸及其相关氨基硫醇的氧化还原状态,这可能有助于加深对它们与脑血管疾病病因关系的理解。